CRISPR-Cas9 technology has opened new avenues in cancer research by allowing precise editing of genes. This can be used to knock out genes that contribute to cancer progression or to repair mutated genes. Additionally, CRISPR can be employed to create more effective CAR-T cells or to engineer immune cells that are resistant to the immunosuppressive environment created by tumors.
